Viral mimicry may help explain immunogenic cell death
Proceedings of the National Academy of Sciences · 17.03.2026 · 123 (11)
DOI: 10.1073/pnas.2537547123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 11.03.2026. Verfasst von Matthew S Levine und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Texas at Austin, Austin, TX 78712-1224. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Molecular Mimicry, Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCRR NIH HHS, Welch Foundation (The Welch Foundation).
Abstract (Originalsprache)
Viral mimicry may be an underappreciated contributor to chemotherapeutic potency in animal models and patients. This hypothesis is based on studies of a bis-Au(I)-NHC complex that was found to generate a strong anti-tumor immune response in vivo in two different challenge studies using an iKAP colorectal cancer mouse model. RNA profiling of treated cells revealed the stimulation of genes that overlap with those upregulated during a viral infection. The bis-Au(I)-NHC complex generates reactive oxygen species (ROS) through the simultaneous redox cycling of the naphthoquinone moiety and inhibition of thioredoxin reductase with Au(I). This ROS increase causes endoplasmic reticulum stress, activation of the unfolded protein response pathway and upregulation of Ifih1, a gene that encodes for the viral dsRNA sensor MDA5. Activation of MDA5 triggers a strong type I interferon response and expression of chemokine ligand 10 that can recruit immune cells to the treated tumor in a manner analogous to immune responses during viral infection. This proposed mechanism bridges the gap between cytotoxicity and the innate and adaptive immune responses. We suggest viral mimicry may be a key driver of chemotherapy potency in animals and an important determinant of positive outcomes in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Texas at Austin, Austin, TX 78712-1224.
- Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054.
- Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712-0159.
ORCID-Profile: Matthew S Levine, Jiexi Li, Lauren I R Ehrlich, Ronald A DePinho, Brent Iverson, Jonathan L Sessler
Förderung
- NCI NIH HHS
- NCRR NIH HHS
- Welch Foundation (The Welch Foundation)
- HHS | NIH (NIH)
Zitieren
APA
Levine, M. S., Li, J., Ehrlich, L. I. R., DePinho, R. A., Iverson, B., & Sessler, J. L. (2026). Viral mimicry may help explain immunogenic cell death. Proceedings of the National Academy of Sciences, 123(11). https://doi.org/10.1073/pnas.2537547123
Vancouver
Levine MS, Li J, Ehrlich LIR, DePinho RA, Iverson B, Sessler JL. Viral mimicry may help explain immunogenic cell death. Proceedings of the National Academy of Sciences. 2026;123(11). doi:10.1073/pnas.2537547123
BibTeX
@article{Levine2026,
author = {Levine, Matthew S and Li, Jiexi and Ehrlich, Lauren I R and DePinho, Ronald A and Iverson, Brent and Sessler, Jonathan L},
title = {Viral mimicry may help explain immunogenic cell death},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {11},
doi = {10.1073/pnas.2537547123}
}
EUVIMED